Market revenue in 2023 | USD 373.3 million |
Market revenue in 2030 | USD 1,082.7 million |
Growth rate | 16.4% (CAGR from 2023 to 2030) |
Largest segment | Tavr (transcatheter aortic valve replacement) |
Fastest growing segment | LAAC (Left Atrial Appendage Closure) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | SAVR (Surgical Aortic Valve Replacement), TAVR (Transcatheter Aortic Valve Replacement), Mitral Repair (Annuloplasty), LAAC (Left Atrial Appendage Closure) |
Key market players worldwide | Boston Scientific Corp, Medtronic PLC, Edwards Lifesciences Corp, Abbott Laboratories, St. Jude Medical, LivaNova PLC, Stryker Corp, Lepu Medical, Biomerics, CardioKinetix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to structural heart devices market will help companies and investors design strategic landscapes.
Tavr (transcatheter aortic valve replacement) was the largest segment with a revenue share of 52.75% in 2023. Horizon Databook has segmented the Canada structural heart devices market based on savr (surgical aortic valve replacement), tavr (transcatheter aortic valve replacement), mitral repair (annuloplasty), laac (left atrial appendage closure) covering the revenue growth of each sub-segment from 2018 to 2030.
The structural heart devices market in Canada is currently undergoing significant expansion, largely propelled by the escalating prevalence of CVDs countrywide. According to Statistics Canada's 2022 report, the mortality rate due to heart disease or stroke far exceeded that of COVID-19 in 2020, with over four times as many Canadians succumbing to these conditions.
Heart disease emerged as the second leading cause of death, claiming 53,704 lives, while stroke ranked fifth, resulting in 13,695 deaths. As the population ages and lifestyle factors contribute to a surge in heart-related ailments, there's a notable surge in demand for structural heart devices.
Key players like Abbott Laboratories and Medtronic Inc. are deeply engaged in the Canadian market, channeling investments into R&D to introduce innovative products tailored to the unique needs of Canadian patients.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada structural heart devices market , including forecasts for subscribers. This country databook contains high-level insights into Canada structural heart devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account